|
|
|
|
By: The NY Times Grady Jackson, a defensive tackle with the Atlanta Falcons, said he used the weight-loss capsules. Kathie Lee Gifford, a former talk show host, was enthusiastic about them on the "Today" show. Retailers like GNC and the Vitamin Shoppe sold them, no prescription required.
But the U.S. Food and Drug Administration now says those weight-loss capsules, called StarCaps and promoted as natural dietary supplements using papaya, could be hazardous to your health. In violation of the law, the agency has found, the capsules also contained a potent pharmaceutical drug called bumetanide which can have serious side effects.
And StarCaps are not the only culprits. In a continuing investigation that has prompted consumer warnings and recalls by some distributors, the FDA has determined that dozens of weight-loss supplements, most of them imported from China, contain hidden and potentially harmful drugs. In the coming weeks, the agency plans to issue a longer list of brands to avoid that are spiked with drugs, an FDA spokeswoman said.
Besides StarCaps, which were made in Peru and which Balanced Health Products, the American distributor, has voluntarily withdrawn, the agency's warning list includes more obscure pills sold under the names Sliminate, Superslim and Slim Up, among many others. So far, the FDA has cited 69 tainted weight-loss supplements.
"A large percentage of these products either contain dangerous undeclared ingredients or they might be outright fraudulent on the ingredients and have no effect at all," said Michael Levy, the director of the FDA's division of New Drugs and Labeling Compliance. "We don't think consumers should be using these products." |
|
Read more... [U.S. drug agency finds 'natural' diet pills laced with drugs]
|
|
|
|
|
|
Developed by: Balanced Health Products, Inc. Use: Dietary Supplement
Background: In December, the FDA issued an immediate recall of Starcaps because the supplement was found to contain an undeclared drug ingredient, Bumetanide. Bumetanide, which is not listed on the label, is a prescription only diuretic indicated for the treatment of edema associated with congestive heart failure, hepatic, and renal disease including nephrotic syndrome. Potential risks associated with the use of Bumetanide include: - Serious fluid and electrolyte loss
- Elevation in uric acid concentrations
- Drug interactions with digoxin and lithium may lead to an increased risk of toxicity.
- Increased risk of hypotension(low blood pressure)
- Fainting
- Resultant injury if you are already taking an antihypertension medication
Action Summary: The FDA is advising consumers who purchased Starcaps Dietary Supplement Capsules with undeclared Bumetanide with lot numbers: to immediately discontinue the use of the recalled product and return it to Balanced Health Products at the address located on the product's label. |
|
|
|
|
|